Fundraising FoxNovomics
2 known investors
Find your way into Novomics
Sign up to see every warm intro you have to Novomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Novomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
South Korean molecular diagnostics company developing gene-based prognostic tests for gastric cancer patients.
Also known as Novomics Co Ltd · Novomics Co., Ltd.
Investors · 2
Company profile
researched Aug 2026Novomics Co Ltd is a company registered in the Republic of Korea operating in the pharmaceutical preparation and biotechnology industry. It develops molecular diagnostic tests intended for cancer gene analysis in gastric (stomach) cancer patients.
The company's offering is a gene-based molecular examination delivered with a diagnostic kit that assesses prognosis following stomach cancer surgery. The stated purpose of the test is to support precision medicine by helping healthcare professionals select appropriate treatment for stomach cancer patients.
Business model
Novomics develops and supplies molecular diagnostic testing, including a diagnostic kit used for gene-based examination of gastric cancer patients.
▸Full profile — market position, technology, go-to-market, geography
Market position
Operates in the pharmaceutical preparation and biotechnology sector, focused on molecular diagnostics for gastric cancer.
Technology
Gene-based molecular examination for cancer gene analysis, provided in the form of a diagnostic kit used to assess prognosis after stomach cancer surgery.
Go-to-market
Healthcare professionals treating stomach cancer patients, and gastric cancer patients undergoing post-surgical prognostic assessment.
Geography
Registered and based in the Republic of Korea.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
▸Research sources · 1
primary sources listed
- Novomics. Information about the issuer. . News and credit ratings. Tables with accounting and financial reports.cbonds.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Novomics do?
- South Korean molecular diagnostics company developing gene-based prognostic tests for gastric cancer patients.
- Who are Novomics's investors?
- Novomics's investors include Aju IB Investment, Kiwoom Investment.